ATX-101 (Aurobac Therapeutics)
N/A
Report date: 2025/08/07 20:00:08
NMEFirst In Class
Base Information
Drug NameATX-101 (Aurobac Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAurobac Therapeutics SAS
China Registration ClassN/A
Develop Information
Active CompaniesAurobac Therapeutics SAS
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A